Cordero-Escobar I, Gutiérrez-Rojas AR

Language: Spanish
References: 20
Page: 151-157
PDF size: 76.61 Kb.

ABSTRACT

To propose an algorithm for the taking of decisions in the anesthetic behavior of the tributary myasthenic patient of surgical treatment. Material and methods: 340 patients were evaluated. Of the general anesthesia we was evaluated the hypnotic, the narcotic, neuromuscular blockers and the used doses. The function neuromuscular was quantified with an accelerometer. The neuromuscular blockers doses were 25% of the habitual doses. Results: The variables of function neuromuscular showed longering values. This values increasing between 0.8 and 2.8 more prolongated especially with cisatracurium to dose 25 µg.kg^-1. We only use maintenance dose with mivacurium because it were compartated as an intermedium action neuromuscular blocker. The half value of the height of the twitch with vecuronium, atracurium and cisatracurium were between 31.5 ± 0.6 and 89.5 ± 0.3%, but in the mivacurium group was › 95%. The stocking of the quotient T₄/T₁ with vecuronium, atracurium and cisatracurium were 45 and 62%. In the mivacurium group was ≥ 81.7 ± 1.1% for what the patients’ 95% was extubates in the theatre. Conclusions: The algorithm propose is easy way the behavior to continue in the tributary myasthenic patient of surgical treatment.

REFERENCES

1. Conducta Anestésica en los pacientes portadores de MG. En: Álvarez Gómez JA, Miranda F. Relajantes musculares en anestesia y cuidados intensivos. 1a edición. Ed. Libro del año. Cap 7.14. Madrid 1996:264-271.

2. Chevalley C, Spiliopoulos A, de Perrot M, Tschopp JM, Licker M. Perioperative medical management and outcome following thymectomy for myasthenia gravis. Can J Anesth 2001;48:446-51.

3. Mann R, Blobner M, Jelen-Esselborn S, Busley R, Werner C. Preanesthetic train-of four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000;93:346-50.

4. Itoh H, Shibata K, Nitta S. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth 2001;87:885-9.

5. Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. The Mount Sinai J Med 2002;69:32-39.

6. Della RG, Coccia C, Dianee A, Pompei L, Costa MG, Tomaselli E, Di Marco P, Vilardi V, Pietropaoli P. Propofol or sevoflurane anesthesia without muscle relaxants allow the early extubation of myasthenic patients. Can J Anesth 2003;50:547-552.

7. Krucylak PE, Naunheim KS. Preoperative preparation and anesthetic management of patients with myasthenia gravis. Semin Thorac Cardiovasc Surg 1999;11:47-53.

8. González-Machado J, Cordero Escobar I, Ortega JL, Gómez CMD. Anestesia en miastenia gravis y enfermedades neuromusculares. En: Torres LM. Tratado de Anestesia y Reanimación Madrid. Ed. Arán 2001:1829-1839.

9. Seigne RD, Scott RPF. Mivacurium chloride and myasthenia gravis. Br J Anaesth 1994;72:468-469.

10. Paterson IG, Hood HR, Rusell SH, Wetson MD, Hirsh NP. Mivacurium in the myasthenic patient. Br J Anaesth 1994;73:494-498.

11. Cordero EI, Parisi LN, Benítez TSM. Miastenia y mivacurio para la timectomía transesternal. Rev Esp Anest Rean 2002; 49:360-364.

12. Mann R, Blobner M, Jelen-Esselborn, Busley R, Werner C. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000;93:346-50.

13. Baraka AS, Taha SK, Kawkabani NI. Neuromuscular interaction of sevoflurane-cisatracurium in a myasthenic patient. Can J Anaesth 2000;47:562-5.

14. Blobner M, Mann R. Anesthesia in patients with myasthenia gravis. Anaesthesist 2001;50:484-93.

15. Devys JM, Guellé M, Corré A, Plaud B. Myasthénie oculaire et monitorage de la curarisation au muscle sourcilier Neuromuscular blockade monitoring at the corrugator supercilii and ocular myasthenia gravis. Cas clinique Annales Françaises d’Anesthésie et de Réanimation 2003;22:242-244.

16. Cordero EI. ¿Atracurio o cisatracurio en los miasténicos quirúrgicos? Rev Cub Anest Rean 2003;2:2-10.

17. Debaene B, Cros AM. La curarisation facilite-t-elle l’intubation trachéale. Ann Fr Anesth Réanim 2000;19:356-66.

18. Itoh H, Shibata K, Yoshida M, Yamamoto K. Neuromuscular monitoring at the orbicularis oculi may overestimate the blockade in myasthenic patients. Anesthesiology 2000;93:1194-7.

19. Baraka AS, Haroun-Bizri ST, Gerges FS. Delayed postoperative arousal following remifentanyl-based anesthesia in a myasthenic patient undergoing thymectomy. Anesthesiology 2004;100: 400-1.

20. Cordero EI, Parisi LN, Espinaco VJ, Pérez MG. ¿Qué dosis de cisatracurio debe utilizarse en los miasténicos quirúrgicos? Rev Mex Anest 2004;27:205-209.